revenues net of producing and distribution expenditures. A drug’s sunk R&D charges—which is, The prices previously incurred in creating that drug—will not influence its selling price. 67 The Prescription Drug Person Price Act, enacted in 1992, offered the FDA with further resources to hasten the drug acceptance approach, which lowered each